Definitions, rates and associated mortality of ICU-acquired pneumonia: A multicenter cohort study.

[1]  Paul W. Dul,et al.  Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial. , 2021, JAMA.

[2]  G. Guyatt,et al.  Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis , 2020, Intensive Care Medicine.

[3]  M. Klompas,et al.  Ventilator-associated pneumonia in adults: a narrative review , 2020, Intensive Care Medicine.

[4]  M. Surette,et al.  Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT , 2019, BMJ Open.

[5]  R. Wunderink,et al.  Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia , 2018, ERJ Open Research.

[6]  Robert W. Taylor,et al.  Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial , 2016, Trials.

[7]  D. Sibbritt,et al.  Incidence of ventilator-associated pneumonia in Australasian intensive care units: use of a consensus-developed clinical surveillance checklist in a multisite prospective audit , 2015, BMJ Open.

[8]  B. Souweine,et al.  Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia* , 2015, Critical care medicine.

[9]  J. Vincent,et al.  Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. , 2015, Chest.

[10]  S. Keenan,et al.  The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. , 2013, Chest.

[11]  D. Cook,et al.  A randomized trial of glutamine and antioxidants in critically ill patients. , 2013, The New England journal of medicine.

[12]  Stijn Vansteelandt,et al.  Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. , 2011, American journal of respiratory and critical care medicine.

[13]  T. Casale,et al.  Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. , 2010, American journal of respiratory and critical care medicine.

[14]  A. Day,et al.  Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[16]  D. Heyland,et al.  The impact of ventilator-associated pneumonia on the Canadian health care system. , 2008, Journal of critical care.

[17]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[18]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[19]  Jonathan Cohen,et al.  The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.

[20]  A. Fein,et al.  Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Executive summary. , 2000, Chest.

[21]  S. Ewig,et al.  Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies , 1999, Thorax.

[22]  R. Auckenthaler,et al.  Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. , 1991, The American review of respiratory disease.

[23]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[24]  M Schumacher,et al.  Attributable Mortality due to Nosocomial Infections , 2007, Methods of Information in Medicine.